Renal Cancer - Results from #5220

Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer April 14, 2017

Dorsal Muscle Attenuation May Predict Failure to Respond to Interleukin-2 Therapy in Metastatic Renal Cell Carcinoma April 14, 2017

Pediatric Patient With Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature April 14, 2017

Hilar Parenchymal Oversew: a novel technique for robotic partial nephrectomy hilar tumor renorrhaphy April 13, 2017

GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients. April 13, 2017

Statin utilization improves oncologic and survival outcomes in patients with dyslipidemia and surgically treated renal cell carcinoma. April 13, 2017

A multi-centered, propensity matched analysis comparing laparoscopic and open surgery for pT3a renal cell carcinoma April 12, 2017

Metastatic polyp of the gallbladder from renal cell carcinoma April 12, 2017

A single thyroid nodule revealing early metastases from clear cell renal carcinoma: case report and review of literature April 12, 2017

Axitinib in sequential therapy in metastatic renal cell carcinoma April 12, 2017

Biomarkers to predict prognosis and response to checkpoint inhibitors April 11, 2017

Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients April 11, 2017

Renal Cell Carcinoma: New Insights and Challenges for a Clinician Scientist April 11, 2017

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related biomarkers for response and toxicity April 10, 2017

Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma April 10, 2017

Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions April 10, 2017

Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - important implications for Epithelial to Mesenchymal Transition (EMT) in Renal Cell Carcinoma. April 7, 2017

Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted Therapy April 7, 2017

New technique for nephron-sparing surgery in polar tumours. A modification of the Kim technique. April 7, 2017

End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomes April 6, 2017

Page 262 of 456